Submitted by Anonymous (not verified) on 24 October 2024 - 12:17
Pharmacovigilance Risk Assessment Committee (PRAC): 1 - 4 September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 1 September 2025 to 4 September 2025
Source: